Gliotransmission: A Novel Target for the Development of Antiseizure Drugs

Volume: 26, Issue: 4, Pages: 293 - 309
Published: Jan 24, 2020
Abstract
For more than a century, epilepsy has remained an incapacitating neurological disorder with a high incidence worldwide. Mesial temporal lobe epilepsy (TLE) is a common type of epilepsy without an effective pharmacological treatment. An increase in excitability and hypersynchrony of electrical neuronal activity during development are typically associated with an excitatory/inhibitory imbalance in the neuronal network. Astrocytes release...
Paper Details
Title
Gliotransmission: A Novel Target for the Development of Antiseizure Drugs
Published Date
Jan 24, 2020
Volume
26
Issue
4
Pages
293 - 309
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.